neobookRx

Stevens-Johnson Syndrome (SJS)/ Toxic Epidermal Necrosis (TEN)

Description Diagnostic criteria General and supportive measures Medicine treatment Referral  ICD-10: L51.1 / L51.2 DESCRIPTION Life-threatening, acute hypersensitivity reaction with systemic upset, epidermal necrosis, and mucous membrane involvement. TEN and SJS are different ends of the same spectrum: in TEN, epidermal necrosis involves > 30% of body surface area, while in SJS the i

Description

Diagnostic criteria

General and supportive measures

Medicine treatment

Referral 


ICD-10: L51.1 / L51.2

DESCRIPTION

Life-threatening, acute hypersensitivity reaction with systemic upset, epidermal necrosis, and mucous membrane involvement. TEN and SJS are different ends of the same spectrum: in TEN, epidermal necrosis involves > 30% of body surface area, while in SJS the involvement is < 10%.

This condition is usually due to medication, e.g. sulphonamides, non-nucleoside reverse transcriptase inhibitors (especially nevirapine), antiepileptics (phenytoin, phenobarbitone, carbamazepine, lamotrigine), allopurinol, laxatives (phenolphthalein).

Complications include:

  • dehydration, electrolyte disturbances and shock,
  • hypoalbuminaemia,
  • hypo- and more commonly hyperthermia,
  • high output cardiac failure,
  • secondary infection and sepsis; and
  • adhesions and scarring.

DIAGNOSTIC CRITERIA

Cutaneous lesions may start as a dusky red macular rash, progressing to confluence with epidermal necrosis and large flaccid blisters which rupture, leaving large areas of denuded skin. Mucous membrane erosions are common and multi-organ involvement may be present.

GENERAL AND SUPPORTIVE MEASURES

  • May require care in high or intensive care unit.
  • Examine daily for systemic involvement, infection and ocular lesions. If infection is suspected, send blood and skin lesion specimens for culture and sensitivity before initiating antibiotic therapy.
  • Do not puncture bullae or vesicles.
  • Cool compresses and wet dressings.
  • Regular supervised oral, genital and eye care to prevent adhesions and scarring.
  • Encourage oral fluids, to prevent adhesions.
  • Maintain fluid balance. Beware of shock.
  • Nasogastric feeds if unable to eat; IV alimentation if enteral feeds are not possible.
  • Stop all potentially causative medicines

MEDICINE TREATMENT

For pain
These patients require effective pain control.
Change of dressing protocol: See Pain Control.

Dressings
Skin hygiene, daily cleansing and bland, non-adherent dressings as needed.

Do not use silver sulfadiazine if Stevens-Johnson syndrome is thought to be due to cotrimoxazole or other sulphonamide.

Empiric antibiotic therapy
For secondary infections:

Use IV antibiotics if the oral route cannot be used.

  • Cloxacillin, IV, 50 mg/kg/dose 6 hourly.

OR

  • Cephalexin, oral, 25 mg/kg/dose 6 hourly.

     Where weight is unknown:
      ◦    Child < 2 years: 125 mg.
      ◦    Child 2–10 years: 250 mg.
      ◦    > 10 years: 500 mg.

OR

  • Flucloxacillin, oral, 25 mg/kg/dose 6 hourly.

LoE: III1

Penicillin allergy:

  • Clindamycin, oral, 6 mg/kg/dose, 6 hourly.

Reconsider choice of antibiotic when the results of cultures become available or the child does not improve.

For oral lesions

  • Chlorhexidine 0.2%, 15 mL as a mouthwash.
    • Use as needed.
    • Do not swallow.

Note: The use of systemic corticosteroids is not recommended.


REFERRAL

  • Discuss with a specialist, if considering re-initiation of medicine treatment.

Standard Treatment Guidelines And Essential Medicines List For South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter 5: Dermatology,  5.2 Erythema And Desquamation,  5.2.2 Stevens-Johnson Syndrome (SJS)/ Toxic Epidermal Necrosis (TEN)

Drugs mentioned

ICD-10 codes

NeoHealth® ID 34745 · updated 4/11/2023